Long considered the holy grail of energy production, in the future fusion could provide clean, carbon-free and non-radioactive electricity production.
Author: Elizabeth Weise and Karen Weintraub, USA TODAY
Omicron is spreading ‘every place at once,’ experts say. What it could mean for holiday plans.
A group of Massachusetts-based researchers say they believe omicron could already account for about 15% of COVID-19 cases in some parts of the U.S.
FDA panel supports J&J COVID-19 vaccine booster shot for all Americans who got a first dose
In an unanimous vote, a federal advisory committee supported boosters of the J&J vaccine for all adults at least two months after a single shot.
FDA authorizes booster dose of Pfizer COVID-19 vaccine for people 65 and older, high-risk workers
The FDA authorized COVID booster doses of the Pfizer-BioNTech vaccine for people 65 and older and those whose jobs put them at high risk for exposure.
FDA panel recommends Pfizer-BioNTech COVID-19 booster shots only for people 65 and older or at high risk
There isn’t yet sufficient evidence to support boosters for people under 65, the FDA Vaccines and Related Biological Products Advisory Committee said.
Moderna says its COVID vaccine found to be 100% effective in children 12 to 17 two weeks after second dose
The Moderna vaccine was 93% effective against COVID-19 in teenagers aged 12 to 17 after the first dose and 100% two weeks after the second dose.
To protect Americans and help the world, US needs to start giving more COVID-19 vaccine away more quickly, experts say
By quickly donating millions of doses of COVID-19 vaccines and setting an example for other nations, the U.S. could help end the global pandemic.
The coronavirus variant that first appeared in India is in the US. Here’s what to know.
Experts say it likely will not cause great harm in the U.S. because of high vaccination rates and our health care system, but they are watching it.
Pause on Johnson & Johnson COVID vaccine in US lifted by FDA, use to resume
The pause on the one-dose J&J COVID vaccine will be lifted and distribution will resume in the U.S., FDA officials said Friday night.
Halt on J&J COVID-19 vaccine will continue in US until more data on rare blood clotting disorder is available
A CDC committee decided to leave a pause on J&J’s one-shot vaccine in place to gather more information on blood clots related to vaccinations.